Citigroup’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6 | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $66 | Sell |
|
|||||
|
2024
Q3 | $800 | Sell |
|
|||||
|
2024
Q2 | $5.53K | Sell |
|
|||||
|
2024
Q1 | $7.89K | Buy |
|
|||||
|
2023
Q4 | $5.08K | Buy |
|
|||||
|
2023
Q3 | $3.28K | Sell |
|
|||||
|
2023
Q2 | $52.7K | Buy |
|
|||||
|
2023
Q1 | $10.1K | Sell |
|
|||||
|
2022
Q4 | $13.3K | Buy |
|
|||||
|
2022
Q3 | $20K | Sell |
|
|||||
|
2022
Q2 | $25K | Buy |
|
|||||
|
2022
Q1 | $41K | Sell |
|
|||||
|
2021
Q4 | $743K | Buy |
|
|||||
|
2021
Q3 | $804K | Sell |
|
|||||
|
2021
Q2 | $2.22M | Buy |
|
|||||
|
2021
Q1 | $2.19M | Buy |
|
|||||
|
2020
Q4 | $234K | Buy |
|
|||||
|
2020
Q3 | $24K | Buy |
|